CME Group (NASDAQ:CME) Price Target Raised to $252.00 at JPMorgan Chase & Co.

CME Group (NASDAQ:CME) had its target price lifted by JPMorgan Chase & Co. from $246.00 to $252.00 in a research note published on Thursday morning,Benzinga reports. JPMorgan Chase & Co. currently has an underweight rating on the financial services provider’s stock.

A number of other brokerages also recently weighed in on CME. Oppenheimer increased their price target on shares of CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a research report on Thursday, July 24th. UBS Group cut their target price on shares of CME Group from $305.00 to $285.00 and set a “neutral” rating on the stock in a report on Monday, September 8th. Barclays set a $298.00 price target on shares of CME Group and gave the stock an “equal weight” rating in a research report on Thursday, July 24th. Piper Sandler upped their price objective on shares of CME Group from $283.00 to $296.00 and gave the company an “overweight” rating in a research report on Tuesday, July 15th. Finally, Citigroup upgraded CME Group from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $275.00 to $300.00 in a report on Thursday. Five investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $268.14.

CME Group Stock Up 1.6%

Shares of CME opened at $268.73 on Thursday. The firm has a market capitalization of $96.84 billion, a price-to-earnings ratio of 26.01, a PEG ratio of 4.79 and a beta of 0.43. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The business’s fifty day moving average price is $270.96 and its two-hundred day moving average price is $270.80. CME Group has a 52 week low of $213.94 and a 52 week high of $290.79.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping analysts’ consensus estimates of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The business had revenue of $1.69 billion during the quarter, compared to analysts’ expectations of $1.68 billion. During the same period in the previous year, the firm earned $2.56 earnings per share. The firm’s quarterly revenue was up 10.4% compared to the same quarter last year. On average, analysts predict that CME Group will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were given a $1.25 dividend. The ex-dividend date was Tuesday, September 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. CME Group’s payout ratio is currently 48.40%.

Insider Activity

In other news, insider Sunil Cutinho sold 11,896 shares of the business’s stock in a transaction dated Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total value of $3,229,407.12. Following the sale, the insider directly owned 17,440 shares in the company, valued at $4,734,436.80. The trade was a 40.55% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, General Counsel Jonathan L. Marcus sold 392 shares of the business’s stock in a transaction dated Thursday, September 18th. The shares were sold at an average price of $262.00, for a total value of $102,704.00. Following the completion of the sale, the general counsel owned 7,851 shares in the company, valued at approximately $2,056,962. This trade represents a 4.76% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 13,043 shares of company stock worth $3,527,956 over the last three months. Corporate insiders own 0.30% of the company’s stock.

Institutional Trading of CME Group

A number of institutional investors have recently modified their holdings of CME. Wayfinding Financial LLC bought a new stake in shares of CME Group in the first quarter valued at about $25,000. Webster Bank N. A. lifted its holdings in shares of CME Group by 206.9% in the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 60 shares in the last quarter. Cornerstone Planning Group LLC increased its position in shares of CME Group by 122.2% in the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 55 shares during the last quarter. Highline Wealth Partners LLC increased its position in shares of CME Group by 84.3% in the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 43 shares during the last quarter. Finally, Golden State Wealth Management LLC increased its position in shares of CME Group by 612.5% in the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock valued at $30,000 after acquiring an additional 98 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.